跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Disodium edetate
首页
药物
Disodium edetate
Disodium edetate
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Method and composition for treating ocular hypertension and glaucoma
EP 2772249 B1
申请人: SANTEN PHARMACEUTICAL CO LTD
优先权: 2008
CN
EP
8 件公开
POSACONAZOLE INTRAVENOUS SOLUTION FORMULATIONS STABILIZED BY SUBSTITUTED BETA-CYCLODEXTRIN
EP 3960185 A1
申请人: MERCK SHARP & DOHME
优先权: 2010
CN
EP
US
6 件公开
PARABEN-FREE FEXOFENADINE FORMULATIONS
EP 4651852 A1
申请人: OPELLA HEALTHCARE GROUP SAS
优先权: 2023
EP
US
WO
4 件公开
Method of improving survival of patients
CN 1217657 C
申请人: ASTRAZENECA AB
优先权: 2000
CN
WO
3 件公开
A COMPOSITION OF A READY TO USE ASCORBIC ACID INJECTION AND A METHOD THEREOF
US 20260240808 A1
申请人: MAIVA PHARMA PRIVATE LTD
优先权: 2022
US
WO
2 件公开
SODIUM DANSHENSU INJECTION AND INDUSTRIAL PRODUCTION METHOD THEREFOR
WO 2026118404 A1
申请人: SHANGHAI ZHONGSHI PHARMACEUTICAL CO LTD
优先权: 2024
CN
WO
2 件公开
Self-emulsifying anhydrous intradermal depot gel
US 11660284 B2
申请人: MEDPHARM HOLDINGS LLC
优先权: 2020
US
2 件公开
US 2023277565 A1
申请人: MEDPHARM HOLDINGS LLC
优先权: 2023
US
COMPOSITIONS AND METHODS FOR THE TREATMENT OF PRESBYOPIA
US 2023398064 A1
申请人: LENZ THERAPEUTICS INC
优先权: 2023
US
2 件公开
US 10959990 B2
申请人: PRESBYOPIA THERAPIES LLC
优先权: 2020
US
Aqueous liquid pharmaceutical composition comprised of gatifloxacin
US 6333045 B1
申请人: SENJU PHARMA CO
优先权: 1998
US
Dental cleaning formulation and manufacturing process
US 6602490 B1
申请人: CLOONAN RICHARD A.
优先权: 2002
US
第 1 / 10 页
上一页
下一页
药物
反馈